Atlas Trials

The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence

Clinical trial NCT01535937 · TERMINATED

Trial details

NCT number
NCT01535937
Sponsor
New York State Psychiatric Institute
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cocaine Dependence
Start date
2012-02-01
Primary completion
2017-01-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.